Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
BIAF holding history
bioAffinity Technologies, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BIAF overviewAll 13F holders of BIAFFull Q2 2026 holdings
- Shares (Q2 2026)
- 3
- Value
- $2
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3 | $2 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 3 | $11 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 3 | $4 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 3 | $9 | <0.1% | −97−97.0% | Reduced | Holders |
| Q2 2025 | 100 | $29 | <0.1% | −200−66.7% | Reduced | Holders |
| Q1 2025 | 300 | $78 | <0.1% | −200−40.0% | Reduced | Holders |
| Q4 2024 | 500 | $455 | <0.1% | −4,461−89.9% | Reduced | Holders |
| Q3 2024 | 4,961 | $10.3K | <0.1% | +3,961+396.1% | Added | Holders |
| Q2 2024 | 1,000 | $2.16K | <0.1% | +1,000 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −3−100.0% | Sold out | Holders |
| Q4 2022 | 3 | $5 | <0.1% | +3 | New | Holders |